US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
SNDK
$1,704.16
▼-0.92%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
SNDK
$1,704.16
▼-0.92%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Aeglea BioTherapeutics, Inc. - Common Stock
(NQ:
AGLE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aeglea BioTherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Mid-Afternoon Market Update: Dow Surges Over 200 Points; Immunic Shares Slide
↗
June 02, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday.
Via
Benzinga
Mid-Day Market Update: U.S. Stocks Turn Positive; Nasdaq Jumps 150 Points
↗
June 02, 2022
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 150 points on Thursday.
Via
Benzinga
Aeglea BioTherapeutics Shares Plummet Following Refusal To File Letter From FDA
↗
June 02, 2022
Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) announced the U.S. Food and Drug Administration (FDA) has refused to accept the company’s Biologics License Application (BLA) with a Refusal to File (RTF)...
Via
Benzinga
Aeglea BioTherapeutics Earnings Perspective: Return On Capital Employed
↗
May 26, 2022
Aeglea BioTherapeutics (NASDAQ:AGLE) brought in sales totaling $1.36 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 19.51%, resulting in a loss of $24.44...
Via
Benzinga
Aeglea BioTherapeutics: Q1 Earnings Insights
↗
May 05, 2022
Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Aeglea Bio Stock Gains On Additional Pegzilarginase Data For Rare Metabolic Disease
↗
April 12, 2022
Via
Benzinga
53 Stocks Moving In Thursday's Mid-Day Session
↗
June 02, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 05, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 13, 2022
Gainers
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More
↗
April 12, 2022
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...
Via
Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
↗
April 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
April 12, 2022
Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
↗
April 10, 2022
Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 17, 2022
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 31.0% to $1.31 during Thursday's pre-market session. The company's market cap stands at $36.7 million....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 16, 2022
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of...
Via
Benzinga
Aeglea BioTherapeutics's Return On Capital Employed Overview
↗
March 10, 2022
Benzinga Pro data, Aeglea BioTherapeutics (NASDAQ:AGLE) reported Q4 sales of $3.64 million. Earnings fell to a loss of $20.45 million, resulting in a 0.68% decrease from last...
Via
Benzinga
Aeglea BioTherapeutics: Q4 Earnings Insights
↗
March 08, 2022
Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
March 02, 2022
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
February 15, 2022
Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 11, 2022
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock rose 29.0% to $1.38 during Friday's pre-market session. The company's market cap stands at $11.4 million. Innoviva...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
February 10, 2022
On Thursday, 89 companies hit new 52-week lows. Noteable 52-Week Lows: The company with the largest market cap to set a new 52-week low was Seagen (NASDAQ:SGEN)....
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
↗
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
February 10, 2022
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 27.1% to $1.36 during Thursday's pre-market session. The company's market cap stands at $11.3...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
February 10, 2022
Good morning, trader! Rub that sleep out our your eyes because we're going over the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
February 09, 2022
Gainers Bone Biologics (NASDAQ:BBLG) shar...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
December 07, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore...
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 700 Points; Del Taco Restaurants Shares Spike Higher
↗
December 06, 2021
Toward the end of trading Monday, the Dow traded up 2.11% to 35,308.84 while the NASDAQ rose 1.24% to 15,272.25. The S&P also rose, gaining 1.51% to 4,607.08. The U.S. has the...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
December 06, 2021
Gainers Adicet Bio (NASDAQ:ACET) shares i...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 3%; Aeglea BioTherapeutics Shares Plunge
↗
December 06, 2021
Midway through trading Monday, the Dow traded up 1.94% to 35,251.31 while the NASDAQ rose 0.55% to 15,168.35. The S&P also rose, gaining 1.20% to 4,592.83. The U.S. has the...
Via
Benzinga
Topics
Stocks
36 Stocks Moving In Monday's Mid-Day Session
↗
December 06, 2021
Gainers Del Taco Restaurants, Inc. (NASDAQ: TACO) shares jumped 64.6% to $12.40. Jack In The Box Inc (NASDAQ: JACK) agreed to acquire Del Taco Restaurants for $12.51 per share...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
